Literature DB >> 27299367

Neurological Manifestations of Mycoplasma pneumoniae Infection in Hospitalized Children and Their Long-Term Follow-Up.

Jessica Kammer1, Stefan Ziesing2, Lukas Aguirre Davila3, Eva Bültmann4, Sabine Illsinger1, Anibh M Das1, Dieter Haffner1, Hans Hartmann1.   

Abstract

Objective In this retrospective study, we aimed to assess frequency, types, and long-term outcome of neurological disease during acute Mycoplasma pneumoniae (M. pneumoniae) infection in pediatric patients. Materials and Methods Medical records of patients hospitalized with acute M. pneumoniae infection were reviewed. Possible risk factors were analyzed by uni- and multivariate regression. Patients with neurological symptoms were followed up by expanded disability status score (EDSS) and the cognitive problems in children and adolescents (KOPKJ) scale. Results Out of 89 patients, 22 suffered from neurological symptoms and signs. Neurological disorders were diagnosed in 11 patients: (meningo-) encephalitis (n = 6), aseptic meningitis (n = 3), transverse myelitis (n = 1), and vestibular neuritis (n = 1), 11 patients had nonspecific neurological symptoms and signs. Multivariate logistic regression identified lower respiratory tract symptoms as a negative predictor (odds ratio [OR] = 0.1, p < 0.001), a preexisting immune deficit was associated with a trend for a decreased risk (OR = 0.12, p = 0.058). Long-term follow-up after a median of 5.1 years (range, 0.6-13 years) showed ongoing neurological deficits in the EDSS in 8/18, and in the KOPKJ in 7/17. Conclusion Neurological symptoms occurred in 25% of hospitalized pediatric patients with M. pneumoniae infection. Outcome was often favorable, but significant sequels were reported by 45%. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2016        PMID: 27299367     DOI: 10.1055/s-0036-1584325

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  6 in total

Review 1.  Mycoplasma pneumoniae from the Respiratory Tract and Beyond.

Authors:  Ken B Waites; Li Xiao; Yang Liu; Mitchell F Balish; T Prescott Atkinson
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

Review 2.  Pathogenesis and Treatment of Neurologic Diseases Associated With Mycoplasma pneumoniae Infection.

Authors:  Renato D'Alonzo; Elisabetta Mencaroni; Lorenza Di Genova; Daniela Laino; Nicola Principi; Susanna Esposito
Journal:  Front Microbiol       Date:  2018-11-20       Impact factor: 5.640

3.  Anesthesia and surgery induce cognitive dysfunction in elderly male mice: the role of gut microbiota.

Authors:  Gaofeng Zhan; Dongyu Hua; Niannian Huang; Yue Wang; Shan Li; Zhiqiang Zhou; Ning Yang; Riyue Jiang; Bin Zhu; Ling Yang; Fan Yu; Hui Xu; Chun Yang; Ailin Luo
Journal:  Aging (Albany NY)       Date:  2019-03-23       Impact factor: 5.682

4.  Real-Time PCR and Quantitative Culture for Mycoplasma pneumoniae Load in Pharyngeal Swabs from Children at Preliminary Diagnosis and Discharge.

Authors:  Fei Zhao; Xuemei Guan; Jing Li; Liyong Liu; Jie Gong; Lihua He; Fanliang Meng; Jianzhong Zhang
Journal:  Biomed Res Int       Date:  2020-01-03       Impact factor: 3.411

5.  The association between Mycoplasma pneumoniae infection and speech and language impairment: A nationwide population-based study in Taiwan.

Authors:  Ching-Shu Tsai; Vincent Chin-Hung Chen; Yao-Hsu Yang; Tai-Hsin Hung; Mong-Liang Lu; Kuo-You Huang; Michael Gossop
Journal:  PLoS One       Date:  2017-07-03       Impact factor: 3.240

Review 6.  Mycoplasma pneumoniae: A Potentially Severe Infection.

Authors:  Bharat Bajantri; Sindhaghatta Venkatram; Gilda Diaz-Fuentes
Journal:  J Clin Med Res       Date:  2018-06-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.